First Time Loading...
Y

Yifan Pharmaceutical Co Ltd
SZSE:002019

Watchlist Manager
Yifan Pharmaceutical Co Ltd
SZSE:002019
Watchlist
Price: 13.24 CNY 3.36% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one Yifan Pharmaceutical Co Ltd stock under the Base Case scenario is 17.22 CNY. Compared to the current market price of 13.24 CNY, Yifan Pharmaceutical Co Ltd is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
17.22 CNY
Undervaluation 23%
Relative Value
Price
Y
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
57
vs Industry
32
Median 3Y
4
Median 5Y
4
Industry
2.4
Forward
3.7
More Details
117.5
P/E
P/E
Price to Earnings
117.5
vs History
15
vs Industry
2
Median 3Y
73.5
Median 5Y
46.2
Industry
22.9
Forward
-34.8
More Details
34.7
P/OCF
P/OCF
Price to OCF
34.7
vs History
42
vs Industry
13
Median 3Y
36.2
Median 5Y
31.1
Industry
17.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
27.1
Industry
23.2
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
82
vs Industry
44
Median 3Y
1.9
Median 5Y
2
Industry
2.1
More Details
4.1
EV/S
EV/S
Enterprise Value to Sales
4.1
vs History
55
vs Industry
31
Median 3Y
4.2
Median 5Y
4.2
Industry
2.6
Forward
3.9
More Details
8.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.6
vs History
73
vs Industry
25
Median 3Y
9.1
Median 5Y
9.1
Industry
5.1
More Details
121.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
121.6
vs History
15
vs Industry
2
Median 3Y
77.5
Median 5Y
46.2
Industry
13.6
Forward
-90.2
More Details
121.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
121.6
vs History
15
vs Industry
3
Median 3Y
77.5
Median 5Y
46.2
Industry
17
More Details
36.2
EV/OCF
EV/OCF
Enterprise Value to OCF
36.2
vs History
42
vs Industry
12
Median 3Y
37.7
Median 5Y
32.5
Industry
15.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-100.8
Median 5Y
-71.3
Industry
17.6
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
82
vs Industry
47
Median 3Y
1.6
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Yifan Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yifan Pharmaceutical Co Ltd
SZSE:002019
15.8B CNY 3.9 117.5 121.6 121.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
734.6B USD 21.5 140.2 63.3 72.6
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17.3 48.1 35.2 38.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
350.3B USD 4.3 8.6 11.5 15.2
US
Merck & Co Inc
NYSE:MRK
330.5B USD 5.5 905.4 45 87.8
UK
AstraZeneca PLC
LSE:AZN
187B GBP 5.1 39.4 140.7 225.7
CH
Novartis AG
SIX:NOVN
182.4B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176B CHF 3 15.3 8.7 10.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.